New disciplines and directions in drug development
‘‘Nuclear Medicine Imaging will be a major focus in drug development efforts in the next decade as we enter a new age of certainty, where diseases will be viewed as molecular dissonance or communication disorder,’’ said Rakesh Kumar Sharma, joint director, Institute of Nuclear Medicine and Allied Sciences (INMAS), Delhi, while highlighting the emergence of radiopharmaceuticals as an important discipline and the development of scanners with higher sensitivity to monitor the functional effects of a drug.

News in brief